Abstract:BACKGROUND: Berberine hydrochloride is a conventional component in Chinese medicine, and is characterized by a diversity of pharmacological effects. However, due to its hydrophobic properties, along with poor stability and bioavailability, the application of berberine hydrochloride was hampered for a long time. In recent years, the pharmaceutical preparation of berberine hydrochloride has improved to achieve good prospects for clinical application, especially for novel nanoparticulate delivery systems. Moreover, anticancer activity and novel mechanisms have been explored, the chance of regulating glucose and lipid metabolism in cancer cells showing more potential than ever. Therefore, it is expected that appropriate pharmaceutical procedures could be applied to the enormous potential for anticancer efficacy, to give some new insights into anticancer drug preparation in Chinese medicine.METHODS AND RESULTS: We accessed conventional databases, such as PubMed, Scope, and Web of Science, using "berberine hydrochloride", "anti-cancer mechanism", and "nanoparticulate delivery system" as search words, then summarized the progress in research, illustrating the need to explore reprogramming of cancer cell metabolism using nanoparticulate drug delivery systems.CONCLUSION: With increasing research on regulation of cancer cell metabolism by berberine hydrochloride and troubleshooting of issues concerning nanoparticulate delivery preparation, berberine hydrochloride is likely to become a natural component of the nanoparticulate delivery systems used for cancer therapy. Meanwhile, the known mechanisms of berberine hydrochloride, such as decreased multidrug resistance and enhanced sensitivity of chemotherapeutic drugs, along with improvement in patient quality of life, could also provide new insights into cancer cell metabolism and nanoparticulate delivery preparation.

Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer

Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy

Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors

Genomic Screening for Targets Regulated by Berberine in Breast Cancer Cells

Synthesis and Anticancer Activity of Novel 9,13-Disubstituted Berberine Derivatives

Design, Synthesis, and Anticancer Activity of Novel Berberine Derivatives Prepared Via CuAAC "click" Chemistry As Potential Anticancer Agents.

Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer.

Total Synthesis and Evaluation of B‐Homo Palmatine and Berberine Derivatives As P300 Histone Acetyltransferase Inhibitors

Novel Triazolyl Berberine Derivatives Prepared Via Cuaac Click Chemistry: Synthesis, Anticancer Activity and Structure-Activity Relationships

Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors

Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo

Antiproliferation of Berberine is Mediated by Epigenetic Modification of Constitutive Androstane Receptor (car) Metabolic Pathway in Hepatoma Cells

Berberine hydrochloride: anticancer activity and nanoparticulate delivery system

Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7.

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents

Berberine Enhances the Anti-Tumor Activity of Tamoxifen in Drug-Sensitive Mcf-7 and Drug-Resistant Mcf-7/Tam Cells

Design, Synthesis and Biological Evaluation of a Novel Spiro Oxazolidinedione As Potent P300/cbp HAT Inhibitor for the Treatment of Ovarian Cancer.

Berberine Inhibits Tumour Growth in Vivo and in Vitro Through Suppressing the Lincror-Wnt/β-catenin Regulatory Axis in Colorectal Cancer.

Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors.

Design, Synthesis and Biological Evaluation of (R)-5-methylpyrrolidin-2-ones As P300 Bromodomain Inhibitors with Anti-Tumor Activities in Multiple Tumor Lines.

Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro.